Laborie Medical Technologies Acquires Urotronic

Laborie Medical Technologies has completed the acquisition of Urotronic, a Plymouth, Minnesota-based developer of the Optilume drug‑coated balloon technology for interventional urology. The deal includes an upfront cash payment (net $232 million to Laborie considering its prior minority stake) and up to $345 million in milestone payments, and brings Urotronic and its employees fully into Laborie to expand Laborie's interventional urology product portfolio globally.